ARTBIO | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Deals

2 January 2024

Bristol makes its radiopharma move

The group’s $4.1bn swoop for RayzeBio follows big deals from Novartis and Lilly.

Subscribe to ARTBIO